Takeda Pharmaceutical Co., Ltd. Lists on NYSE

Category: US IPO

Author: Accounting Monster

Post Date: Feb 28, 2019

Last Edit: Nov 13, 2025

On December 24, 2018, Takeda Pharmaceutical Co., Ltd. was listed on the NYSE. In conjunction with this event, we have updated our “U.S. Securities Market Guide Part 1: NYSE Listing by Japanese Companies.”

https://quantum.accountants/ja/usipo_series1/

Share News on Social

Contact

Please feel free to contact us regarding financial and accounting challenges that directly impact your business decisions, such as M&A, organizational restructuring, or a Nasdaq IPO.
Kindly fill out and submit the inquiry form. A representative will contact you shortly.

Contact Us by Phone

+81-3-6805-0933

Contact Us by Phone

+81-3-6805-0933

Takeda Pharmaceutical Co., Ltd. Lists on NYSE

Recent News

Mr. Shinya Sakata, Former Manager at KPMG Azsa, Joins Quantum Accounting

The OTC Market as a Stepping Stone to U.S. Exchange Listing: The Strategic Potential of Uplisting

Announcement: Quantum Accounting Joins GSV Global M&A Network

Speaking at a Money Forward Online Seminar

Goodwill Accounting Treatment to Shift Toward Impairment Model. Is the World Instead Returning to the Amortization Model?

Popular News

A Guide to the US Capital Markets for Japanese Companies Vol.1

The Light and Shadow of SPACs: SBC’s NASDAQ Listing and JEPLAN’s Abandoned Listing – The Challenge for Japanese Companies Amid the Tumultuous Waves of Redemption

Announcement of Miyuki Zeniya Representative of evergreen, Joining Our Company

Goodwill Accounting Treatment to Shift Toward Impairment Model. Is the World Instead Returning to the Amortization Model?

(Interview Part 1) The Challenge of a Nasdaq IPO: The Path Forged by Kura Sushi USA ~The Former CFO Recounts the Two-Year Journey to Listing~

Categories

Contact

Contact Us by Phone

Contact Us by Phone